Dr. Varalaxmi Nannaka, M.D.
What this data tells you about Dr. Nannaka
Dr. Varalaxmi Nannaka is a critical care medicine in Tyler, TX, with 14 years in practice. Based on federal Medicare data, Dr. Nannaka performed 1,966 Medicare services across 1,412 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nannaka received a total of $10,712 from 28 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nannaka is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min | 481 | $164 | $614 |
| Hospital follow-up visit, moderate complexity | 244 | $62 | $163 |
| Hospital follow-up visit, high complexity | 187 | $91 | $234 |
| Test to examine how well the lungs exchange gases | 151 | $7 | $30 |
| Test to determine lung volumes using sensors | 138 | $9 | $40 |
| New patient office visit (45-59 min) | 125 | $98 | $365 |
| Test to measure expiratory airflow and volume | 116 | $6 | $52 |
| Chest X-ray, 2 views | 80 | $7 | $33 |
| Initial hospital admission, high complexity | 71 | $132 | $457 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 64 | $6 | $406 |
| Aspiration of initial secretion of lung airway using an endoscope | 58 | $75 | $885 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 43 | $63 | $996 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 39 | $8 | $91 |
| Office visit, established patient (20-29 min) | 28 | $48 | $160 |
| Office visit, established patient (30-39 min) | 27 | $77 | $238 |
| Aspiration of fluid from chest cavity | 26 | $67 | $280 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 20 | $106 | $327 |
| Exam of lung airways using an endoscope | 16 | $0 | $440 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 15 | $95 | $984 |
| Insertion of artery tube for blood sampling or infusion through skin | 13 | $35 | $250 |
| Initial hospital admission, moderate complexity | 13 | $94 | $308 |
| Test for exercise-induced lung stress | 11 | $16 | $90 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nannaka is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (speaking/promotional, top 13%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nannaka experienced with critical care, first 30-74 min?
Does Dr. Nannaka receive payments from pharmaceutical companies?
How do Dr. Nannaka's costs compare to other critical care medicines in Tyler?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology